Stock GVS GVS S.P.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials GVS S.p.A.

Equities

GVS

IT0005411209

Medical Equipment, Supplies & Distribution

Market Closed - Borsa Italiana
Other stock markets
 16:44:59 03/05/2024 BST 		5-day change 1st Jan Change
5.48 EUR -0.54% Intraday chart for GVS S.p.A. +0.37% -1.70%
04-09 Mib correction at 34,000; strength on Fincantieri AN
04-09 Lists bearish; DiaSorin rises against the tide AN

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,669 1,847 706.9 974.4 957.7 - -
Enterprise Value (EV) 1 2,642 1,943 706.9 1,303 1,240 1,183 1,125
P/E ratio - - 28.9 x 69.7 x 23.7 x 17.5 x 14.8 x
Yield 0.85% - - - - 1.33% 2.26%
Capitalization / Revenue 7.35 x 5.38 x 1.8 x 2.25 x 2.15 x 2.04 x 1.92 x
EV / Revenue 7.27 x 5.66 x 1.8 x 3.01 x 2.79 x 2.53 x 2.26 x
EV / EBITDA 18.3 x 18 x 8.95 x 13.7 x 11.6 x 9.34 x 7.9 x
EV / FCF - - - 17.8 x 25.6 x 18.4 x 16 x
FCF Yield - - - 5.63% 3.91% 5.43% 6.23%
Price to Book - - - - 2.55 x 2.21 x 2 x
Nbr of stocks (in thousands) 175,000 175,067 174,550 174,773 174,759 - -
Reference price 2 15.25 10.55 4.050 5.575 5.480 5.480 5.480
Announcement Date 19/03/21 22/03/22 21/03/23 26/03/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 363.3 343.1 392 432.4 445 468.6 498.5
EBITDA 1 144.1 107.9 79 95.1 106.7 126.6 142.5
EBIT 1 128.6 89.3 54.8 67.4 79.5 96.88 112.5
Operating Margin 35.4% 26.03% 13.98% 15.59% 17.87% 20.68% 22.57%
Earnings before Tax (EBT) 1 - - 34.6 18.3 54.5 75 88.5
Net income 1 - - 24.1 13.6 40.25 55.15 64.8
Net margin - - 6.15% 3.15% 9.04% 11.77% 13%
EPS 2 - - 0.1400 0.0800 0.2310 0.3135 0.3700
Free Cash Flow 1 - - - 73.39 48.45 64.25 70.15
FCF margin - - - 16.97% 10.89% 13.71% 14.07%
FCF Conversion (EBITDA) - - - 77.17% 45.41% 50.74% 49.23%
FCF Conversion (Net income) - - - 539.65% 120.37% 116.5% 108.26%
Dividend per Share 2 0.1300 - - - - 0.0727 0.1240
Announcement Date 19/03/21 22/03/22 21/03/23 26/03/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2
Net sales 1 68.87 81.53 - - 116 104.9 109.4 213.4 99.74 114.6 103.8 113.6
EBITDA - - - - - 22.6 - - 21.64 27.84 - -
EBIT - - - - - 12.1 - - 15.23 18.4 - -
Operating Margin - - - - - 11.53% - - 15.27% 16.06% - -
Earnings before Tax (EBT) - - - - - - - - - - - -
Net income - - 32.44 12.64 - 2.5 - - 8.469 -2.2 - -
Net margin - - - - - 2.38% - - 8.49% -1.92% - -
EPS - - 0.1900 0.0700 - - - - - - - -
Dividend per Share - - - - - - - - - - - -
Announcement Date 10/11/21 22/03/22 30/07/22 11/11/22 21/03/23 15/05/23 07/09/23 07/09/23 09/11/23 26/03/24 - -
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - 96.5 - 329 282 226 168
Net Cash position 1 26.7 - - - - - -
Leverage (Debt/EBITDA) - 0.8944 x - 3.456 x 2.643 x 1.782 x 1.175 x
Free Cash Flow 1 - - - 73.4 48.5 64.3 70.2
ROE (net income / shareholders' equity) - - - 4.12% - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share 2 - - - - 2.150 2.480 2.750
Cash Flow per Share 2 - - - 0.6000 -0.0100 0.2600 0.2900
Capex 1 - - - 28.2 31.6 28.4 29.7
Capex / Sales - - - 6.52% 7.1% 6.05% 5.95%
Announcement Date 19/03/21 22/03/22 21/03/23 26/03/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for GVS S.p.A.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
5.48 EUR
Average target price
6.367 EUR
Spread / Average Target
+16.18%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Supplies

1st Jan change Capi.
GVS S.P.A. Stock GVS S.p.A.
-1.70% 1.03B
COLOPLAST A/S Stock Coloplast A/S
+11.40% 27.92B
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED Stock Shandong Weigao Group Medical Polymer Company Limited
-30.75% 3.08B
WINNER MEDICAL CO., LTD. Stock Winner Medical Co., Ltd.
-15.97% 2.53B
INTCO MEDICAL TECHNOLOGY CO., LTD. Stock Intco Medical Technology Co., Ltd.
+18.11% 2.47B
HARTALEGA HOLDINGS Stock Hartalega Holdings
+7.78% 2.1B
HARBIN FUERJIA TECHNOLOGY CO., LTD. Stock Harbin Fuerjia Technology Co., Ltd.
-9.47% 1.91B
TOP GLOVE CORPORATION BHD. Stock Top Glove Corporation Bhd.
-0.56% 1.51B
NAKANISHI INC. Stock Nakanishi Inc.
+2.24% 1.34B
KANGJI MEDICAL HOLDINGS LIMITED Stock Kangji Medical Holdings Limited
+3.86% 1.13B
Medical Supplies
  1. Stock Market
  2. Equities
  3. GVS Stock
  4. Financials GVS S.p.A.